Related Experiment Video
Updated: Jul 17, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
RNF183 Induces Polarization of M2 Macrophages by Regulating Ubiquitination of PML and Promotes Lung Cancer
Lu Xu1, Chenlin Lu1
1Department of Respiratory Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, China.
Introduction/Objective:
Macrophage polarization affects the progression of lung cancer. This study aimed to explore the potential mechanism whereby M2 macrophages accelerate the progression of lung cancer.
Methods:
The differentiation of THP-1 cells to M2 macrophages was elicited by IL-4/IL-13 treatment, which was verified by CD68+CD206+ cells detected through flow cytometry. M0- and M2-polarized macrophages' conditioned medium (M0-CM and M2- CM) were co-cultured with lung cancer cells. Real-time quantitative PCR, western blots, flow cytometry, CCK-8 assay, clone formation, wound healing assay, transwell, co-immunoprecipitation, and cycloheximide assays were utilized to explore the interaction of RING finger 183 (RNF183) and M2 macrophages and their mechanism of regulating lung cancer progression.
Results:
RNF183 is a potential mediator that regulates M2 macrophage polarization. RNF183 promotes the growth, migration, and invasive behavior of lung cancer cells by stimulating the polarization of M2 macrophages. Mechanistically, RNF183 regulates ubiquitin modification in the promyelocytic leukemia (PML) protein to down-regulate PML and accelerate polarization of M2 macrophages. Moreover, RNF183 knockdown decreased the malignant progression of lung cancer cells co-cultured with M2-CM, while PML knockdown reversed the effect of RNF183 silencing.
Discussion:
Our findings identify RNF183 as a previously unrecognized regulator of M2 macrophage polarization in lung cancer. By linking RNF183-mediated ubiquitination of PML to macrophage phenotype switching, this study extends the current understanding of how post-translational modifications in immune cells shape the tumor microenvironment. Given that M2-polarized tumor-associated macrophages are associated with poor prognosis and therapy resistance in lung cancer, targeting the RNF183/PML axis may offer a novel immunomodulatory strategy. These insights also highlight the broader relevance of RNF183 in cancer immunity beyond its cell-autonomous functions.
Conclusion:
Our findings revealed that RNF183 facilitates lung cancer progression by inducing M2 macrophage polarization via regulating ubiquitination of PML.
Insights
RING finger 183 (RNF183) drives lung cancer progression by promoting M2 macrophage polarization. This occurs through RNF183-mediated ubiquitination of the promyelocytic leukemia (PML) protein, impacting tumor growth and invasion.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Macrophage polarization significantly influences lung cancer development.
- M2 macrophages are implicated in accelerating lung cancer progression.
Purpose of the Study:
- To elucidate the mechanism by which M2 macrophages promote lung cancer progression.
- To investigate the role of RING finger 183 (RNF183) in M2 macrophage polarization and lung cancer growth.
Main Methods:
- THP-1 cells were differentiated into M2 macrophages using IL-4/IL-13.
- Co-culture systems with lung cancer cells and M2 macrophage-conditioned medium were established.
- Techniques included flow cytometry, qPCR, western blots, CCK-8, clone formation, wound healing, transwell, co-immunoprecipitation, and cycloheximide assays to study RNF183 and PML interactions.
Main Results:
- RNF183 was identified as a key regulator of M2 macrophage polarization.
- RNF183 enhances lung cancer cell proliferation, migration, and invasion by stimulating M2 polarization.
- Mechanistically, RNF183 targets PML for ubiquitination, down-regulating PML and promoting M2 polarization; RNF183 knockdown inhibited cancer progression, which was reversed by PML knockdown.
Conclusions:
- RNF183 is a novel regulator of M2 macrophage polarization in lung cancer.
- The RNF183/PML axis, involving ubiquitination, influences macrophage phenotype and the tumor microenvironment.
- Targeting the RNF183/PML pathway presents a potential immunomodulatory strategy for lung cancer treatment.
Related Concept Videos
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...